Skip to main content

TG Therapeutics, Inc. (NASDAQ: TGTX) Investor Securities Class Action Lawsuit 07/18/2022

  • If you purchased a significant amount of shares of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, and / or if you purchased any NASDAQ: TGTX shares prior to January 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: September 16, 2022. NASDAQ: TGTX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

January 26, 2023 - Judgment was entered. January 13, 2023 - The court issued an order granting motion to dismiss. The case was dismissed with prejudice. November 17, 2022 - A motion was filed to dismiss the amended complaint. October 28, 2022 - An amended complaint was filed. July 18, 2022 - An investor in shares of TG Therapeutics, Inc. (NASDAQ: TGTX) filed a lawsuit in the U.S. Dist...



You must register (for free) or login to view the entire case.